At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...

With Men’s Health Week approaching, it is a good time to encourage open discussions about various health conditions, particularly prostate health. Driven by embarrassment, misconceptions, and a lack ...

Led by Prof Santosh Kumar, the urology team at Chandigarh’s PGIMER completes a marathon session of four robotic radical ...

Freedom from distant metastasis (FFDM) at 10 years was 93% with adjuvant RT and 90% with salvage treatment. After a median follow-up of 7.8 years, 52 patients in the adjuvant RT arm had died as ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Dr. Robert Uzzo answers the question: 'Who Gets Robotic/Laparoscopic Surgery?' Jan. 01, 2009 -- Question: Who is an appropriate candidate for a laparoscopic or robot-assisted prostatectomy? Answer: ...

Urologic surgeon Jose M. Flores, MD is lead author of a new study investigating the risk of biochemical recurrence after radical prostatectomy when taking ED drugs. There have been conflicting studies ...

The marathon session, conducted on January 1 from 8 am to 5 pm, was led by Prof Santosh Kumar, head of the urology team.